NCT02337777

Brief Summary

The purpose of this study is to study the diagnostic efficiency of functional magnetic resonance imaging in Abdominal and Pelvic Diseases.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2014

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

January 9, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 14, 2015

Completed
4.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

January 17, 2018

Status Verified

January 1, 2018

Enrollment Period

5.4 years

First QC Date

January 9, 2015

Last Update Submit

January 15, 2018

Conditions

Keywords

Magnetic Resonance ImagingMagnetic Resonance AngiographyDiffusion Tensor ImagingIDEALT2* mappingMagnetic ResonanceCineBOLDphase contrastdiffusion-weighted imagingFunctional Magnetic Resonance Imaging

Outcome Measures

Primary Outcomes (1)

  • all cause mortality

    10years

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

All patients with abdominal or pelvic diseases who provide informed consent Healthy Volunteers

You may qualify if:

  • All patients with abdominal or pelvic diseases who provide informed consent
  • Healthy Volunteers

You may not qualify if:

  • claustrophobic
  • pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Tongji Hospital affiliated to Tongji Medical college of Huazhong Universitity of Science and Technology

Wuhan, Hubei, 430030, China

RECRUITING

Related Publications (3)

  • Tang H, Wang Z, Wang L, Hu X, Wang Q, Li Z, Li J, Meng X, Wang Y, Hu D. Depiction of transplant renal vascular anatomy and complications: unenhanced MR angiography by using spatial labeling with multiple inversion pulses. Radiology. 2014 Jun;271(3):879-87. doi: 10.1148/radiol.14131800. Epub 2014 Mar 3.

  • Wang YC, Hu DY, Hu XM, Shen YQ, Meng XY, Tang H, Li Z. Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study. Chin Med J (Engl). 2016 Mar 20;129(6):665-71. doi: 10.4103/0366-6999.177995.

  • Wang Y, Li Z, Meng X, Hu X, Shen Y, Morelli J, Lin H, Zhang Z, Hu D. Nonmuscle-invasive and Muscle-invasive Urinary Bladder Cancer: Image Quality and Clinical Value of Reduced Field-of-view Versus Conventional Single-shot Echo-planar Imaging DWI. Medicine (Baltimore). 2016 Mar;95(10):e2951. doi: 10.1097/MD.0000000000002951.

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD,Professor

Study Record Dates

First Submitted

January 9, 2015

First Posted

January 14, 2015

Study Start

July 1, 2014

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

January 17, 2018

Record last verified: 2018-01

Locations